You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ledipasvir

Showing 1 - 25 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Chronic Trial in Mansoura (Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet
  • Mansoura, Egypt
    Mansoura University Children Hospital
Oct 21, 2021

Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],

Completed
Has Results
  • Hepatitis B
  • Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
  • +2 more
  • Baltimore, Maryland
    Institute of Human Virology (IHV), University of Maryland Baltim
Aug 24, 2021

Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Elbasvir / Grazoprevir Oral Tablet [Zepatier]
  • Cardiac MRI
  • Washington, District of Columbia
  • +1 more
Feb 1, 2023

Hepatitis C and HIV Coinfection Trial in Aurora (Blood draws for tenofovir PK, renal function)

Completed
  • Hepatitis C and HIV Coinfection
  • Blood draws for tenofovir PK, renal function
  • Aurora, Colorado
    University of Colorado Hospital
Aug 10, 2021

COVID Trial in Helwan, Assiut (Sofosbuvir and Ledipasvir, Nitazoxanide)

Completed
  • COVID
  • Helwan, Cairo, Egypt
  • +1 more
Nov 10, 2020

Covid19 Trial in Cairo (Sofosbuvir plus Ledipasvir)

Completed
  • Covid19
  • Sofosbuvir plus Ledipasvir
  • Cairo, Egypt
    Almaza Military Fever Hospital
Aug 27, 2020

Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF

Completed
Has Results
  • Hepatitis C
  • HIV Coinfection
  • TDF with a boosted protease inhibitor
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 21, 2021

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

HCV Infection, Beta Thalassemia Major Trial in Cairo (Sofosbuvir and Ledipasvir)

Unknown status
  • HCV Infection
  • Beta Thalassemia Major
  • Sofosbuvir and Ledipasvir
  • Cairo, Egypt
    Masri-Crc
Apr 16, 2020

Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

Completed
Has Results
  • Hepatitis C
  • Cryoglobulinemia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 23, 2020

Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with

Completed
Has Results
  • Chronic Hepatitis C
  • SOF/LDV (sofosbuvir/ledipasvir)
  • +3 more
  • Little Rock, Arkansas
  • +37 more
Dec 1, 2021

Hepatitis C, Pregnancy Trial in Pittsburgh (ledipasvir/sofosbuvir)

Completed
  • Hepatitis C
  • Pregnancy
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital
Mar 2, 2020

Hepatitis C Virus Infection Trial in Cairo (LDV/SOF)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Cairo, Egypt
    National Cancer Institute, Cairo University
Feb 18, 2020

Hepatitis C Virus Infection Trial in Taiwan (LDV/SOF)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Changhua, Taiwan
  • +10 more
Feb 18, 2020

Hepatitis C, Chronic, Heart Failure, Pulmonary Disease, Chronic Obstructive Trial in United States (Sofosbuvir/ledipasvir fixed

Completed
Has Results
  • Hepatitis C, Chronic
  • +3 more
  • Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC)
  • Detroit, Michigan
  • +3 more
Apr 8, 2020

Insulin Resistance, Hepatitis C Trial in Alexandria (Sofosbuvir 400 milligram, Daclatasvir 60 milligram, Ribavirin 400

Completed
  • Insulin Resistance
  • Hepatitis C
  • Sofosbuvir 400 milligram
  • +3 more
  • Alexandria, Egypt
    Faculty of Medicine
Jun 30, 2020

Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)

Completed
  • Hepatitis C
  • Tanta, Egypt
  • +1 more
Aug 1, 2020

Hepatitis C, Chronic Kidney Disease Trial in Boston (Sofosbuvir/Ledipasvir FDC)

Terminated
Has Results
  • Hepatitis C
  • Chronic Kidney Disease
  • Sofosbuvir/Ledipasvir FDC
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 8, 2020

Genotype 1 Hepatitis C Virus Trial in Omaha (harvoni)

Unknown status
  • Genotype 1 Hepatitis C Virus
  • Omaha, Nebraska
    University of Nebraska
Dec 9, 2019

Hepatitis C, Chronic, Children, Only Trial in Shebin El-Koom (Sofosbovir/Lepipasvir (200/45mg) tablet (Heterosofir))

Completed
  • Hepatitis C, Chronic
  • Children, Only
  • Sofosbovir/Lepipasvir (200/45mg) tablet (Heterosofir)
  • Shebin El-Koom, Menofiya, Egypt
    Pediatric Hepatology, Gastroenterology and Nutrition Department,
Sep 15, 2019

Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF, RBV)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Birmingham, Alabama
  • +30 more
Feb 18, 2020

IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir

Withdrawn
  • Hepatitis C Virus
    • (no location specified)
    Jul 8, 2019

    Chronic Hepatitis C Trial in Cairo (sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir)

    Unknown status
    • Chronic Hepatitis C
    • sofosbuvir plus daclatasvir
    • Sofosbuvir plus Ledipasvir
    • Cairo, Abbasseya, Egypt
      El Demerdash Hospital
    Dec 28, 2019

    Chronic HCV Infection Trial in China, Korea, Republic of, Taiwan (LDV/SOF)

    Completed
    Has Results
    • Chronic HCV Infection
    • Beijing, China
    • +44 more
    Feb 18, 2020